11:20 AM EST - Aptose Biosciences Inc. : Announced that preclinical data for CG’806, its pan-FLT3/pan-BTK inhibitor, and APTO-253, its c-Myc inhibitor, will be presented in three separate posters at the 2018 AACR Annual Meeting in Chicago. Aptose Biosciences Inc.
shares T.APS are trading up $0.30 at $5.15.
